Dana-Farber Tells Fed. Circ. Not To Revisit Inventorship Ruling

By Tiffany Hu · September 15, 2020, 6:08 PM EDT

The Dana-Farber Cancer Institute is urging the full Federal Circuit not to reconsider a panel decision requiring a pair of American scientists to be named as co-inventors on patents involved in...

To view the full article, register now.

Try a seven day FREE Trial

Already a subscriber? Click here to login

Documents

Case Information

Case Title

Dana-Farber Cancer Institute v. Ono Pharmaceutical Co., Ltd.

Case Number

Court

Appellate - Federal Circuit

Nature of Suit

830 Patent Infringement (Fed. Question)

Date Filed

June 19, 2019

Recent Articles By Tiffany

June 13, 2023
Spinal Device Co. Gets $6M Bond Cut In Trade Secrets Suit
March 27, 2023
Wholesaler To Pay $33.4M In Abbott Labs Test Strips TM Row
February 16, 2023
TTAB Won't Let Diagnostic Co. Register 'NF-Light' TM
February 07, 2023
Instacart Co-Founder Hit With TRO In Trade Secrets Fight
January 20, 2023
Brand Battles: Uber Tries To Drive Out 'Uberhorny' Dating TM
January 04, 2023
TTAB Rejects Health Care Co.'s TM As Descriptive
March 21, 2022
Justices Skip $420M Secrets Suit, 'Candy Colors' Fight & More
March 09, 2022
Alvotech, AbbVie Deal Allows For Humira Biosimilar In 2023
February 25, 2022
Brand Battles: BetterUp Takes Aim At 'BetterHelp' Trademark
February 08, 2022
Sun Pharma, Lupin Agree To Drop Eye Pain Patent Dispute